Related Experiment Video
Updated: Sep 20, 2025

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
SMAD4 Controls Cancer Cell Metabolism by Regulating Methylmalonic Aciduria Cobalamin Deficiency (cbl) B Type
Kyoung Song1,2, Hun Seok Lee3,2, Lina Jia4
1College of Pharmacy, Duksung Women's University, Seoul 01366, Korea.
Abstract:
Suppressor of mothers against decapentaplegic homolog (SMAD) 4 is a pluripotent signaling mediator that regulates myriad cellular functions, including cell growth, cell division, angiogenesis, apoptosis, cell invasion, and metastasis, through transforming growth factor β (TGF-β)-dependent and -independent pathways. SMAD4 is a critical modulator in signal transduction and functions primarily as a transcription factor or cofactor. Apart from being a DNA-binding factor, the additional SMAD4 mechanisms in tumor suppression remain elusive. We previously identified methyl malonyl aciduria cobalamin deficiency B type (MMAB) as a critical SMAD4 binding protein using a proto array analysis. This study confirmed the interaction between SMAD4 and MMAB using bimolecular fluorescence complementation (BiFC) assay, proximity ligation assay (PLA), and conventional immunoprecipitation. We found that transient SMAD4 overexpression down-regulates MMAB expression via a proteasome-dependent pathway. SMAD4-MMAB interaction was independent of TGF-β signaling. Finally, we determined the effect of MMAB downregulation on cancer cells. siRNA-mediated knockdown of MMAB affected cancer cell metabolism in HeLa cells by decreasing ATP production and glucose consumption as well as inducing apoptosis. These findings suggest that SMAD4 controls cancer cell metabolism by regulating MMAB.
Insights
Suppressor of mothers against decapentaplegic homolog (SMAD) 4 regulates cancer cell metabolism by interacting with methyl malonyl aciduria cobalamin deficiency B type (MMAB). SMAD4 controls MMAB expression, impacting cancer cell ATP production, glucose consumption, and apoptosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Suppressor of mothers against decapentaplegic homolog (SMAD) 4 is a key mediator in transforming growth factor β (TGF-β) signaling, regulating critical cellular processes.
- The precise mechanisms of SMAD4 in tumor suppression beyond its transcription factor role are not fully understood.
- Methyl malonyl aciduria cobalamin deficiency B type (MMAB) was previously identified as a SMAD4 binding protein.
Purpose of the Study:
- To confirm and characterize the interaction between SMAD4 and MMAB.
- To investigate the effect of SMAD4 on MMAB expression and the role of MMAB in cancer cell metabolism.
Main Methods:
- Proto array analysis, bimolecular fluorescence complementation (BiFC), proximity ligation assay (PLA), and immunoprecipitation were used to confirm SMAD4-MMAB interaction.
- SMAD4 overexpression and siRNA-mediated knockdown of MMAB were employed.
- Cancer cell metabolism was assessed by measuring ATP production and glucose consumption, and apoptosis was evaluated.
Main Results:
- The interaction between SMAD4 and MMAB was confirmed through multiple experimental assays.
- SMAD4 overexpression led to a proteasome-dependent downregulation of MMAB expression, independent of TGF-β signaling.
- MMAB knockdown in HeLa cells significantly altered cancer cell metabolism, reducing ATP production and glucose consumption, and inducing apoptosis.
Conclusions:
- SMAD4 directly interacts with MMAB, and this interaction is independent of TGF-β signaling.
- SMAD4 regulates cancer cell metabolism, at least in part, by controlling MMAB expression.
- Targeting the SMAD4-MMAB pathway may offer novel strategies for cancer therapy by modulating cancer cell metabolism.
More Related Videos
Related Concept Videos
Biosynthesis of Nucleic Acids
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Inborn Errors of Metabolism
Epigenetic Regulation
X-chromosome...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

